Stockreport

Arbutus Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Arbutus Biopharma Corporation  (ABUS) 
Last arbutus biopharma corporation earnings: 11/6 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.arbutusbio.com/node/5806
PDF Strong financial position with cash, cash equivalents and marketable securities of $93.7M  Moderna litigation U.S. trial scheduled for March 2026;Favorable claim constru [Read more]